Loading...

Medpace Holdings, Inc.

MEDPNASDAQ
Healthcare
Medical - Diagnostics & Research
$453.05
$5.56(1.24%)

Medpace Holdings, Inc. (MEDP) Company Profile & Overview

Explore Medpace Holdings, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Medpace Holdings, Inc. (MEDP) Company Profile & Overview

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOAugust James Troendle

Contact Information

513 579 9911
5375 Medpace Way, Cincinnati, OH, 45227

Company Facts

5,900 Employees
IPO DateAug 11, 2016
CountryUS
Actively Trading

Frequently Asked Questions

;